dc.contributor.author
Maleitzke, Tazio
dc.contributor.author
Wiebe, Edgar
dc.contributor.author
Huscher, Dörte
dc.contributor.author
Spies, Cornelia M.
dc.contributor.author
Tu, Jinwen
dc.contributor.author
Gaber, Timo
dc.contributor.author
Zheng, Yu
dc.contributor.author
Buttgereit, Frank
dc.contributor.author
Seibel, Markus J.
dc.contributor.author
Zhou, Hong
dc.date.accessioned
2025-09-03T11:01:02Z
dc.date.available
2025-09-03T11:01:02Z
dc.identifier.uri
https://refubium.fu-berlin.de/handle/fub188/49065
dc.identifier.uri
http://dx.doi.org/10.17169/refubium-48788
dc.description.abstract
Background Disruption of glucocorticoid (GC) signaling in osteoblasts results in a marked attenuation of acute antibody-induced arthritis. The role of endogenous GCs in chronic inflammatory arthritis is however not fully understood. Here, we investigated the impact of endogenous GC signaling in osteoblasts on inflammation and bone integrity under chronic inflammatory arthritis by inactivating osteoblastic GC signaling in a long-term K/BxN serum transfer-induced induced arthritis (STIA) model. Methods Intracellular GC signaling in osteoblasts was disrupted by transgenic (tg) overexpression of 11beta-hydroxysteroid dehydrogenase type 2 (11ss-HSD2). Inflammatory arthritis was induced in 5-week-old male tg mice and their wild type (WT) littermates by intraperitoneal (i.p.) injection of K/BxN serum while controls (CTRLs) received phosphate-buffered saline (PBS). In a first cohort, K/BxN STIA was allowed to abate until the endpoint of 42 days (STIA). To mimic rheumatic flares, a second cohort was additionally injected on days 14 and 28 with K/BxN serum (STIA (boost)). Arthritis severity was assessed daily by clinical scoring and ankle size measurements. Ankle joints were assessed histopathologically. Systemic effects of inflammation on long bone metabolism were analyzed in proximal tibiae by micro-computed tomography (& mu;CT) and histomorphometry. Results Acute arthritis developed in both tg and WT mice (STIA and STIA (boost)) and peaked around day 8. While WT STIA and tg STIA mice showed a steady decline of inflammation until day 42, WT STIA (boost) and tg STIA (boost) mice exhibited an arthritic phenotype over a period of 42 days. Clinical arthritis severity did not differ significantly between WT and tg mice, neither in the STIA nor in the STIA (boost) cohorts. Correspondingly, histological indices of inflammation, cartilage damage, and bone erosion showed no significant difference between WT and tg mice on day 42. Histomorphometry revealed an increased bone turnover in tg CTRL and tg STIA (boost) compared to WT CTRL and WT STIA (boost) animals, respectively. Conclusions In contrast to the previously reported modulating effects of endogenous GC signaling in osteoblasts during acute K/BxN STIA, this effect seems to perish during the chronic inflammatory and resolution phase. These findings indicate that endogenous GC signaling in osteoblasts may mainly be relevant during acute and subacute inflammatory processes.
en
dc.rights.uri
https://creativecommons.org/licenses/by/4.0/
dc.subject
rheumatoid arthritis
en
dc.subject
joint inflammation
en
dc.subject.ddc
600 Technik, Medizin, angewandte Wissenschaften::610 Medizin und Gesundheit::610 Medizin und Gesundheit
dc.title
Transgenic disruption of endogenous glucocorticoid signaling in osteoblasts does not alter long-term K/BxN serum transfer-induced arthritis
dc.type
Wissenschaftlicher Artikel
dcterms.bibliographicCitation.articlenumber
140
dcterms.bibliographicCitation.doi
10.1186/s13075-023-03112-9
dcterms.bibliographicCitation.journaltitle
Arthritis Research & Therapy
dcterms.bibliographicCitation.number
1
dcterms.bibliographicCitation.originalpublishername
Springer Nature
dcterms.bibliographicCitation.volume
25
refubium.affiliation
Charité - Universitätsmedizin Berlin
refubium.funding
Springer Nature DEAL
refubium.resourceType.isindependentpub
no
dcterms.accessRights.openaire
open access
dcterms.bibliographicCitation.pmid
37542341
dcterms.isPartOf.eissn
1478-6362